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Junctional adhesion molecules (JAMs) that are expressed in endothelial and epithelial cells and function in tight junction assembly, also perform
important roles in testis where the closely-related JAM-A, JAM-B, and JAM-C are found. Disruption of murine Jam-B and Jam-C has varying
effects on sperm development and function; however, deletion of Jam-A has not yet been studied. Here we show for the first time that in addition to
expression in the Sertoli–Sertoli tight junctions in the seminiferous tubules, the ∼32 kDa murine JAM-A is present in elongated spermatids and in
the plasma membrane of the head and flagellum of sperm. Deletion of Jam-A, using the gene trap technology, results in flagellar defects at the
ultrastructural level. In Jam-A-deficient mice, which have reduced litter size, both progressive and hyperactived motility are significantly affected
(Pb0.0001) before and, more severely, after capacitation. The findings show that JAM-A is involved in sperm tail formation and is essential for
normal motility, which may occur via its signal transduction and protein phosphorylation properties. Detection of JAM-A in human sperm proteins
indicates that its role may be conserved in sperm motility and that JAM-A may be a candidate gene for the analysis of idiopathic sperm motility
defects resulting in male subfertility in the human population.
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Spermiogenesis is a developmental program in which hap-
loid round spermatids, the product of meiosis, undergo complex
morphological changes and become transformed into polarized
spermatozoa (Weinbauer et al., 2000). At the end of sperm-
iogenesis, sperm are morphologically mature, with nuclear
condensation and well-developed acrosome and tail formation.
However, functional maturity is attained after they leave the
testis, and motility is not acquired until after their passage in the
corpus epididymis (Yeung and Cooper, 2002). As might be
expected, a large number of genes are known to be haploid-
expressed and to be involved in the differentiation of spermatids
into mature sperm (Shima et al., 2004).
One gene that has been recently shown to be involved in
spermatid differentiation is Junctional Adhesion Molecule C
(Jam-C) which encodes a membrane protein, JAM-C (Gliki et⁎ Corresponding author. Fax: +1 302 831 2281.
E-mail address: pdeleon@udel.edu (P.A. Martin-DeLeon).
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doi:10.1016/j.ydbio.2007.10.013al., 2004). Present at the Sertoli-spermatid junctional plaques,
JAM-C anchors elongated spermatids to the Sertoli cell epi-
thelium and is essential for the polarization of round spermatids
during sperm morphogenesis (Gliki et al., 2004). The JAM
protein family members belong to the immunoglobulin super-
family (IgSF) and contain two extracellular Ig-like domains and
a short cytoplasmic domain which flank a single transmembrane
region (Mandell and Parkos, 2005; Bazzoni, 2003; Naik and
Eckfield, 2003). The extracellular Ig-like domains mediate
heterophilic (Bazzoni et al., 2000; Babinska et al., 2002) and
homophilic interactions (Ostermann et al., 2002; Barton et al.,
2001). In general, these proteins play multifunctional roles in a
variety of cellular processes and are involved in cell–cell
adhesion, the assembly of tight junctions, and signal transduc-
tion (Mandell and Parkos, 2005; Bazzoni, 2003; Naik and
Eckfield, 2003). Other family members of the JAM membrane
proteins include JAM-A, JAM-B, JAM-D (JAM-4), and JAML.
JAM-A, -B, and -C are more closely related to each other than to
any other IgSF proteins, with the sequence identity among them
being 32–38% (Ebnet et al., 2004).
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expressed in mouse spermatogenesis (Gliki et al., 2004; Mruk
and Cheng, 2004). Specifically JAM-A and -B are present at the
Sertoli–Sertoli tight junctions, where they maintain an immu-
nological blood–testis barrier, and JAM-B is also present at the
junctional plaques connecting Sertoli cells with round and
elongated spermatids (Gliki et al., 2004). This suggests that
Jam-B partners with Jam-C in their involvement in Sertoli
cell-spermatid communication (Gliki et al., 2004). However,
while deletion of Jam-C significantly affects mouse spermatid
differentiation, particularly sperm head development, leading
ultimately to infertility (Gliki et al., 2004), homozygotes for
Jam-B deletion have normal male and female fertility and
there is an absence of detectable developmental or sperm ab-
normalities (Sakaguchi et al., 2006). To date, the effects of Jam-
A deletion on sperm development and function have not been
investigated. Thus the goal of this study was to use gene
targeting to determine the effect of JAM-A on male germ cells.
Materials and methods
Reagents-immunological and non-immunological
All non-immunological reagents were purchased from Sigma Chemical Co.
(St. Louis, MO) unless otherwise specified. Four different JAM-A antibodies
that were previously validated were used throughout the study. A goat anti-
mouse JAM-A polyclonal antibody, JAM-A-affinity-purified was obtained from
R&D Systems, Inc., Cat# AF1077 and has been previously documented (Cooke
et al., 2006). A rabbit polyclonal anti-human JAM-A that is peptide-affinity-
purified and cross-reacts with mouse JAM-Awas obtained from Zymed (ZMD
#275; Zymed, South San Francisco, CA). The peptide is from the C-terminus. A
monoclonal rat anti-mouse JAM-A antibody, BV12, previously validated
(Martinez-Estrada et al., 2001) was obtained from Abcam, and a mouse anti-
human JAM-A, M.Ab F11, validated by Naik et al., 1995, was purchased fromFig. 1. Genetic structure of murine Jam-A and the gene ablation strategy used to gener
mutant allele generated a truncated fusion protein with amino acids encoded by theBD Pharmingen. A monoclonal mouse PECAM-1 (Platelet endothelial cell
adhesion molecule-1 antibody was obtained from BD Pharmingen). Finally, a
monoclonal Heat shock cognate protein 70 (HSC 70) Ab was purchased from
Santa Cruz Biotechnology (CA).
Generation of Jam-A-deficient mice
The gene trap approach (Skarnes et al., 1992; Leighton et al., 2001) was used
to generate mice homozygous for the null allele of Jam-A. The 12 kb gene trap
vector consisting of β-geo (fusion between β-galactosidase and neomycin) and
the human placental alkaline phosphatase genes (Skarnes et al., 1992) was inserted
between exons 4 and 5. It generated a truncated JAM-A-β-galactosidase fusion
protein containing the first Ig-like domain of the JAM-A protein (Fig. 1). Jam-A
null mice are on the C57BL/6 background and they were genotyped and screened
as described (Cooke et al., 2006). All experimental protocols were approved by
the University of Delaware Institutional Animal Care and Use Committee.
Developmental reverse transcriptase-PCR analysis
Testes of mice at various developmental stages, ranging from day 4 to 21 and
adult mice were collected. Total RNA was prepared from the tissues using the
TRI reagent as previously described (Zheng et al., 2001). One microgram of
total RNA was used to synthesize the first strand with Omniscript RT Kit
(Qiagen) under conditions recommended by the manufacturer. The primers were
designed based on the cDNA sequence: the forward (nt 66–86) is in exon 2, the
reverse (nt 507–527) is in exon 5. Reaction conditions were as follows: 94 °C
for 2 min, followed by 35 cycles of 94 °C for 1 min, 52 °C for 1 min, and 72 °C
for 1 min. The PCR products were resolved in a 1.5% agarose gel and stained
with ethidium bromide. All experiments were repeated at least twice.
Immunohistochemistry of the testis and confocal microscopy
Testes from 3- to 4-month-old sexually mature wild-type (WT) and
Jam-A−/− males were weighed. For cryosections, testis were embedded in
Tissue Tek OCT compound, snap frozen, and stored at −80 °C. Sections, 6 μm
thick, were cut on a freezing microtome and mounted on slides. For
immunostaining, the sections were fixed in acetone: methanol, 1:1 for 10 minate Jam-A−/−mice. The gene trap vector was inserted between exon 4 and 5. The
first 4 exons of Jam-A and the β-geo gene.
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Tissue sections were incubated in 1:100 dilution of goat anti-mouse JAM-A
polyclonal antibody (R&D Systems) in PBS containing 1% BSA followed by a
1:300 dilution of secondary antibody, Alexafluor 568-conjugated donkey anti-
goat IgG (Molecular Probes, Invitrogen, Carlsbad, CA) or primary monoclonal
mouse PECAM-1 (Platelet endothelial cell adhesion molecule-1, BD Phar-
mingen) (1:50) and Alexafluor 488-conjugated donkey anti-rat secondary
antibody (Molecular Probes, Invitrogen,) diluted 1:200. PECAM is used as a
marker for endothelial cells where JAM-A is expressed. All reactions were
performed in a humidified chamber at RT. Since the primary antibody is JAM-A-
affinity-purified, control samples were treated only with the secondary antibody.
Sections were viewed using LSM510 laser scanning confocal microscope.
Collection of sperm and assessment of sperm counts
Caudal epididymides from sexually mature males, WT and null, were finely
minced in 1 ml PBS at 37 °C and sperm were allowed to swim out into the buffer
for 10 min. After sperm dispersion in the suspension, tissue fragments were
separated by gravity settling. The suspension was then centrifuged at 500 rcf for
15 min to pellet the sperm without breaking their membranes (Katkov and
Mazur, 1998). Sperm pellets were washed twice by centrifugation and resus-
pended in PBS. Prior to washing, sperm counts were determined by diluting aFig. 2. Jam-A transcription and protein localization in WT testis but not in Jam-A nul
of WT testis. RNAwas subjected to first strand synthesis with (+) or without (−) reve
of Jam-A cDNAwas detected in every stage (upper panel). Actin is used as control t
transcription is detected in WT testis but not in Jam-A null testis. (C) Confocal micro
and JAM-A null mice (middle panel) were incubated with either pAb JAM-A and
Primary antibodies were detected with Alexafluor-conjugated secondary antibodies.0.5 μl sample of each sperm suspension 1:20 and counting the number of sperm
in a hemocytometer to obtain the concentration. The concentrations were used to
determine the total number of sperm in the original 1 ml volume in which the
sperm were suspended. The average sperm counts from the control and from the
test group were then compared.
Immunocytochemistry (ICC) and flow cytometry
ICC and flow cytometry were performed to determine if JAM-A could be
localized on the sperm surface of mature caudal sperm, and if so to quantify its
presence. Sperm collected as described above were fixed in 1.5% paraformal-
dehyde (v/v in PBS), rinsed twice in PBS. Samples were incubated for 10 min
with PBS containing 0.25% Triton X-100 for permeabilization, since the
antibody that was used was raised against an amino acid sequence in the
cytoplasmic tail of JAM-A. Samples were then washed in PBS three times.
They were then treated with PBS+2% BSA blocking solution for 30 min at RT,
before exposure to rabbit polyclonal anti-human JAM-A that is peptide-
affinity-purified and cross-reacts with mouse JAM-A (ZMD #275; Zymed,
South San Francisco, CA) suspended in 2% BSA block (1:400 dilution) for 1 h
at RT. Control slides were treated with non-immune rabbit IgG. After rinsing
thrice in PBS, sperm were treated with FITC-conjugated anti-rabbit IgG
secondary antibody resuspended in blocking solution (1:400 dilution) forl mice. (A) RT-PCR results of Jam-A expression in various developmental stages
rse transcriptase, followed by PCR amplification. The expected 460 bp fragment
o show that the same amount of RT product was used (lower panel). (B) Jam-A
scopy of JAM-A in mouse testis: Cryostat sections of testis from WT (top panel)
mAb against PECAM-1 or no primary antibody for the control (lower panel).
The scale bar represents 20 μm.
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resuspended in 20–40 μl PBS and 10–20 μl of each sample was spread on
microscope slides and allowed to dry in the dark. Dried samples were stained
with p-phenylenediamine antifade with 1.5 μg/ml of 4′,6-diamidino-2-phenyl-
indole (DAPI), sealed under a coverslip with clear nail polish and imaged using
a Zeiss Axioskop with the appropriate FITC filter set. Images were obtained
with the use of a charged coupled device-cooled camera (Photometrics, Tucson,
AZ) and software from IPLab Spectrum Module (Scanalytics, Fairfax, VA).
Flow cytometry
For flow cytometry samples were prepared as described above for ICC, except
that the controls were treated with BSA instead of preimmune serum. Following
the PBS rinses after exposure to the secondary antibody, samples were analyzed
using a FACSCalibur (Becton Dickinson, San Jose, CA) flow cytometer, which
uses an argon laser at 488 nm with detectors for FITC and a Cell Quest software
package. Fluorescence was measured in samples of 50,000 cells each.
Immunoelectron microscopy
Caudal sperm were washed by centrifugation at 500 rcf for 15 min in PBS.
The pellet was fixed in 4% paraformaldehyde, postfixed in Osmium (1% for 1 h)
and resin (EPON 812; Electron Microscopy Sciences, Hatfield, PA), embedded,
sectioned, and placed on membrane coated transmission electron microscope
(TEM) grids. Sections were immunostained for JAM-A using polyclonal goat
anti-mouse-JAM-A primary antibody (1:40, R&D Systems, Inc. Cat# AF1077)
and a 10 nm gold-conjugated donkey anti-goat IgG (1:20, Electron Microscopy
Science, Cat# 25805) secondary antibody. Grids were washed in filtered PBS,
rinsed in filtered ddH2O, and stained in phosphotungstic acid (PTA) before
being subjected to the TEM (Zeiss CEM 902) analysis. Grids treated without
primary antibody were used as controls.
Preparation of protein extracts and Western blot analysis
Protein extracts were prepared from the testes of sexually mature 3-month-
old mice, from caudal epididymal sperm, and from two human sperm samples
by manually homogenizing the tissues and cells (using a mortar and pestle) in a
solubilization buffer (62.5 mM Tris–HCl, 10% glycerol, 1% SDS, 1 mM PMSF,
pH 6.8) at 4 °C. The suspensions were centrifuged at 10,000×g for 10 min at
4 °C, and the supernatant containing the proteins was collected. The protein
concentration was determined by using a biocinchoninic acid protein assay kitFig. 3. Testis cross-sections of WT and Jam-A null (KO) mice show normal(Pierce, Rockford, IL). An equal mass (40 μg) of each protein sample was used
for all experiments. Samples were exposed to reducing conditions [99 °C for
4 min in the presence of 100 mM dithiothreitol (DTT)] and processed according
to standard protocols (Sambrook and Russell, 2001). Western blotting was
performed with the Western Breeze Chemiluminescent Immunodetection Kit
(Invitrogen, Carlsbad, CA) according to the manufacturer’s protocol. The
membrane for the mouse proteins was probed with monoclonal rat anti-mouse
JAM-A antibody, BV12 (1:1000) (Abcam), followed by a horse radish
peroxidase(HRP)-conjugated secondary donkey anti-rat antibody (1:10,000)
(Jackson ImmunoResearch Laboratories). Human proteins were probed with
mouse anti-human JAM-A (M.Ab F11; BD Pharmingen) as the primary
antibody and a HRP-conjugated anti-mouse IgG as the secondary antibody.
Sperm motility assay
The initial microscopic analysis of sperm using the hemocytometer for sperm
counts, as described above, revealed that there were spermmotility defects in the
Jam-A null mice. Spermwere thus subjected to computer-assisted sperm analysis
(CASA) in PBS (uncapacitated condition) and in human tubal fluid (HTF
medium, Specialty Media) (capacitated condition) using a method similar to that
described by Cheng et al. (2007). After 1 h incubation at 37 °C with gassing with
5% CO2 and 95% O2 to pH 7.3, aliquots of each sperm suspension were loaded
into a 100 μm deep disposable chamber (Microcell; Conception Technologies,
San Diego, CA, USA) pre-warmed at 37 °C. Computer-assisted sperm motion
analysis was performed using a Hamilton Thorne digital image analyzer (HTR-
IVOS v 10.8 s; Hamilton Thorne Research). At least 300 spermatozoa and five
fields were assessed from each animal.
Eight motion parameters were quantified in this study: (1) motility (%); (2)
progressive (prog) motility (%); (3) hyperactivated (hyper) motility (%); (4)
curvilinear velocity (VCL, μm/s); (5) progressive or straight-line velocity
(VSL, μm/s); (6) average path velocity (VAP, μm/s); (7) straightness (STR, %)
(the ratio between VSL and VAP); (8) linearity (LIN, %) (the ratio between VSL
and VCL). The settings used during the analysis were the following: frames
acquired, 30; frame rate, 60 Hz; minimum contrast, 85; minimum cell size, 4
pixels; straightness threshold, 80%; low VAP cut off, 5 μm/s; medium VAP cut
off, 25 μm/s; head size – non-motile, 12 pixels; head intensity – non-motile, 130
Units (U); static head size, 0.68–2.57 pixels; static head intensity, 0.31–1.21 U;
static elongation, 23–100%. The playback function was used to accurately
identify motile cells. Hyperactivated motility (%) was defined as motility with
starspin or high-amplitude thrashing patterns and short trajectory distances
(Burkman, 1984). The criteria for detecting hyperactivated sperm were:
VCLN150 μm/s; LINb50% (Mortimer et al., 1998; Cheng et al., 2007).seminiferous tubules in the latter after hematoxylin and eosin staining.
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Jam-A is expressed in the testis in both somatic and germ cells
The average testicular weights did not differ significantly
(PN0.05) between WT (0.12 gm) and Jam-A−/− (0.10 gm)
males. Developmental RT-PCR revealed that testicular Jam-AFig. 4. JAM-A protein is present in mature caudal mouse epididymal sperm. (A) Imm
and the midpiece, and proximal region of the principal piece of the flagella (A1). Co
staining seen in Jam-A null sperm treated with either the primary antibody or the non
BSA as control (B-1) and JAM-A primary antibody (B-2) shows right shifts in the fl
Western blot shows an ∼32 kDa band that was detected in protein extracts from Wtranscripts from WT mice are expressed in the pre-meiotic
stages and as early as 4 days post-parturition (Fig. 2A), a period
when germ cells begin to implant into the basement membrane
of the seminiferous tubules (McLean et al., 2003). The ex-
pression of testicular Jam-A RNA continues through adulthood
and Fig. 2B shows its absence in Jam-A−/− mice, due to the
insertion of the gene trap vector. In adults, JAM-A protein canunocytochemistry shows JAM-A to be localized on the acrosome on the heads,
ntrol sperm treated with non-immune IgG show no staining (A-2). Neither was
-immune IgG (A-3, A-4). (B) Flow cytometry of 50,000 WT sperm treated with
uorescence peak in the latter, indicating the increased fluorescence intensity. (C)
T sperm, but not in Jam-A null sperm.
Table 1
Kinematic results obtained by CASA for cauda sperm from WTand Jam-A K/O
mice
Parameters Uncapacitated Capacitated
WT Jam-A K/O WT Jam-A K/O
Sperm # 8111 7501 7681 7773
% Mobile 76±0.5 72±0.5 a 74±0.5 56±0.6 b
% Prog 76±0.5 71±0.5a 73±0.5 54±0.6b
% Hyper 8±0.3 7±0.3 c 15±0.4 11±0.4b
VAP 133.5±4.0 117.2±5.9 d 121.1±10.0 89±18.3
VSL 99.1±3.6 93.2±5.8 82.2±7.2 62.1±12.7
VCL 230.8±9.2 189.8±16.8 218.4±16.8 157.9±31.6
STR 73.7±2.5 78.1±3.9 65.3±1.7 70.7±4.4
LIN 45.7±3.0 53.6±7.5 38.6±1.5 45.6±6.1
Fisher's exact test for parameters (average ±SEM): % Motile. % Prog, or
% Hyper. t-test for parameters (average±SEM): VAP. VSL. VCL. STR, and LIN.
a Pb0.0001, compared to respective WT uncapacitated controls.
b Pb0.0001, compared to respective WT uncapacitated controls.
c Pb0.01, compared to WT uncapacitated control.
d Pb0.05, compared to WT uncapacitated control sperm.
251M. Shao et al. / Developmental Biology 313 (2008) 246–255be detected in the seminiferous tubules in the Sertoli cells as
well as in spermatids in images from confocal microscopy (Fig.
2C). While the expression in Sertoli cells is very abundant, as
revealed by the intense immunopositive staining, it is relatively
moderate and diffuse in spermatids in the adluminal compart-
ment of the seminiferous epithelium. Thus there appears to be
different levels of expression of JAM-A in somatic and germ
cells of the testis. The immunostaining in the Sertoli cells was
localized in the basal compartment of the seminiferous epithe-
lium where the tight junctions forming the blood–testis barrier
are found. Fig. 3 shows that there were no histological differ-
ences in appearances of the seminiferous tubules in WTand null
mice, consistent with the similar testicular weights observed.
JAM-A is present on mature caudal epididymal sperm
To determine if JAM-A is present on mature sperm and to
detect its subcellular distribution, caudal sperm from both WT
and Jam-A null mice were subjected to immunocytochemistry
(ICC). The protein was detected almost uniformly over the
acrosome on the head, the midpiece of the flagellum, and the
proximal region of the principal piece (Fig. 4A-1). No signal was
detected in the control sperm treated with non-immune IgG (Fig.
4A-2), neither was it seen in Jam-A null sperm treated with either
the primary antibody or the non-immune IgG (Figs. 4A-3, A-4).
To quantify and confirm the expression of the JAM-A in
sperm, flow cytometry was performed. The control sperm that
were treated with BSA showed an arithmetic histogram with a
mean of 12.44 compared to 36.42 in the antibody-treated
sample. This was reflected in a right shift in the fluorescence
peaks (Figs. 4B-1, B-2). Finally, we verified the presence of the
protein in epididymal sperm by performing Western blots on
extracts from both WT and Jam-A null sperm. Our results show
a band of the expected size (∼32 kDa) in the WT sperm extracts
but not in the null protein extracts (Fig. 4C), confirming the
ablation of the gene in the Jam-A−/−mice and the expression of
the protein in morphologically mature male germ cells.Jam-A−/− mice have reduced litter sizes and sperm motility
defects
In a parallel communication, we showed that the mating of
Jam-A+/− animals produced progeny in the ratio of 1:1.7:0.6
(+/+, +/−, −/−), indicating a significant deviation from the 1:2:1
Mendelian ratio with an approximately 40% deficiency in null
mice and that litter sizes for Jam-A−/− were reduced (Cooke et
al., 2006). Interestingly, there was a sex ratio distortion in the
progeny of Jam-A−/− mice in favor of females (Cooke et al.,
2006). To investigate the basis for these observations, we assessed
sperm counts and motility in WTand Jam-A−/− mice under non-
capacitating and capacitating conditions using CASA. Sperm
counts showed no statistically significant difference between WT
and null mice: for 6 pairs of mice, the average counts were 6.2±
2.8×106 and 6.6±2.1×106, respectively. At the light micro-
scopic level, there appeared to be no difference in sperm
morphology in the two groups; however, spermmotility appeared
impaired and thus sperm were further analyzed by TEM.
CASA revealed in Table 1 that for both capacitated and un-
capacitated sperm, the percentages of total motile and prog-
ressively motile spermatozoa in null mice were significantly
lower than in WT mice (Pb0.0001). This was also the case for
hyperactivated motility where the level of significance was
higher in capacitated (Pb0.0001), than in uncapacitated (Pb
0.01) sperm; suggesting a more severe defect in the Jam-A null
sperm during their final maturation period in the female tract.
Our results for TEM and immunogold staining revealed the
presence of JAM-A on the surface of the head and in the
midpiece of WT mice (Fig. 5A), again confirming the ICC and
the flow cytometry data. TEM also showed that there were fla-
gellar defects present in a high proportion of Jam-A null sperm
(Fig. 5B). The most remarkable defect was seen in the mito-
chondrial sheath of the midpiece (MP) where there was a highly
significant increase of condensed mitochondria with increased
electron density in the Jam-A null sperm compared to WT
sperm. Similarly, in 40 sections, WT sperm had no defects (0%)
in the principal piece (PP) while there was 2/15 or 12% in the
null sperm. It should be noted that the WT sperm and the sperm
with the Jam-A disruption are of the same C57BL/6 background.
To determine if human JAM-A might also be involved in
sperm function, we investigated if JAM-A protein is present in
human sperm extracts, using Western analysis. Protein extracts
of sperm donations from two males showed a band of∼32 kDa,
indicating the presence of JAM-A (Fig. 6).
Discussion
Testis size and sperm numbers are not affected by disruption of
Jam-A
Our results from confocal microscopy (Fig. 2) and in vitro
culture of Sertoli cells (data not shown) revealed that JAM-A is
localized in Sertoli cells at the basal compartment where the
Sertoli–Sertoli tight junctions are found, confirming previous
findings (Gliki et al., 2004; Mruk and Cheng, 2004). Despite the
role of Sertoli cells in providing structural support and
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an impermeable and immunological barrier in the testis, and in
participating in germ cell movement and spermiation (Wein-
bauer et al., 2000), disruption of Jam-A did not appear to affect
testis size, sperm numbers, or the gross sperm morphological
appearance. This finding is similar to that for Jam-B deletion
where mice were shown to have normal spermatogenesis and
testicular and sperm morphology (Sakaguchi et al., 2006). Since
normal spermatogenesis depends on functional interactions
between reproductive germ cells and somatic Sertoli cells where
both JAM-A and JAM-B are localized, it appears that these two
JAM proteins compensate for the loss of each other with respect
to Sertoli cell function and that the interactions are homophilic.
The importance of the role of Sertoli–Sertoli cell interaction in
spermatogenesis is underscored by the functional redundancy of
these two JAM protein family members.
Jam-A is expressed in spermatids and mature spermatozoa of
wild-type mice
Based on the findings by Gliki et al. (2004), JAM-A was
reported to be localized in the testis only at the Sertoli–Sertoli tight
junctions. However, our immunohistochemical analysis clearly
shows that spermatids, both round and elongated, are immunopo-
sitive for JAM-A. Thus this is the first report of the presence of
JAM-A in germ cells, implicating a role in spermiogenesis, as is the
case for JAM-C (Gliki et al., 2004), and in sperm function. The
presence of JAM-A in germ cells is supported by the finding of the
protein in epididymal caudal sperm by Western blotting and
confirmed by immunocytochemistry, flow cytometry, and immu-
noelectron microscopy. Importantly, the detection of JAM-A in
human sperm reveals that it is conserved and therefore suggests an
important role for this protein in mammalian male germ cells. Our
detection of JAM-A in human sperm has been recently confirmed
by another groupwhich also showed the protein to be present in the
human testis (Gye et al., 2007).
JAM-A is required for normal sperm motility
Although JAM-A and JAM-B appear to play redundant roles
in maintaining the blood–testis barrier, that is conducive to
producing normal spermatogenesis, they have different roles
with respect to sperm function. Disruption of Jam-A results in
severe motility defects, particularly after capacitation, while
there is no functional impairment with Jam-B deletion (Saka-
guchi et al., 2006). The lack of impairment of Jam-B deletion is
not surprising since, unlike Jam-A, it does not appear to be
present in spermatids or spermatozoa (Gliki et al., 2004;
Sakaguchi et al., 2006), although it is present with Jam-C in the
Sertoli-spermatid junctional plaques (Gliki et al., 2004). ThisFig. 5. (A) Immunoelectron microscopic analysis of JAM-A protein in WT sperm con
sperm demonstrates the presence of JAM-A on the surface of the midpiece (1, 2) and o
primary antibody, shows the gold particles randomly distributed. (B) TEM images of t
pronounced defect in the mitochondrial sheath of the latter. In 145 sections from
condensed mitochondria (χ2=15.76; Pb0.001) in null sperm compared to control
frequency compared to WT (3).redundancy of Jam-B with both Jam-A and Jam-C may lead to
functional compensation when Jam-B is inactivated. It is inte-
resting that while deletion of Jam-C leads to complete infertility
due to impairment in the differentiation of round spermatids into
spermatozoa, deletion of Jam-Awhich results in sperm motility
defects is associated with reduced litter size and subfertility
(Cooke et al., 2006). In human populations as well as in mice,
fertility is dependent not only on sperm numbers, but also on
their morphology and motility.
Our CASA results revealed that the percentages of motile
spermatozoa and progressive and hyperactivated motility were
significantly (Pb0.01; Pb0.0001) lower in null mice, in both
capacitated and uncapacitated groups. The mean VAP value for
uncapacitated sperm from Jam-A−/− mice was significantly
lower than for WT. Interestingly, in the Jam-A null sperm after
capacitation, all three velocity parameters and the ratios (STR
and LIN) had very large standard errors of the means (Table 1)
compared to those of the WT sperm (18.3 vs. 10, 12.7 vs. 7.2,
31.6 vs. 16.8, 4.4 vs. 1.7, 6.1 vs. 1.5). This suggests dramatic
variations among individual Jam-A null sperm. Since hyper-
activated motility is a characteristic of capacitated sperm and the
differences were more severe after capacitation (Pb0.0001 vs.
Pb0.01), it appears that JAM-A plays a more important role
in motility after the final maturation of sperm in the oviduct than
in their progressive motility in the uterus. Hyperactivated moti-
lity seen after capacitation is characterized by the development
of high velocity, large amplitude, and asymmetrical flagellar
waves (Cooper and Yeung, 2000). Thus it plays important phy-
siological roles including prevention of entrapment, improve-
ment of the chances of oocyte contact, and assistance in
cumulus penetration and in zona penetration (Suarez and Dai,
1992). Reduction of these activities in Jam-A null sperm could
lead to reduced numbers of fertilized oocytes and ultimately
reduced litter sizes. Thus future studies will focus on
determining if the subfertility seen in Jam-A−/− mice is male-
or female-derived.
Our observations of the ultrastructure of WT and Jam-A null
sperm show significantly (Pb0.001) higher percentages of
dysplasia of the mitochondrial sheaths and the principal piece in
sperm from the latter, indicating a role for JAM-A in tail
formation. They also suggest that defects in the flagellum, in
both the mitochondrial sheath in the midpiece and the proximal
principal piece, may be responsible for the motility defects.
Although the large majority of the ATP used in basal sperm
motility are obtained by glycolysis (Mukai and Okuno, 2004),
hyperactivated motility may be dependent on ATP obtained by
oxidative phosphorylation occurring in the mitochondria in the
midpiece of the flagellum.
Interestingly, the condensed electron dense mitochondria
seen in high frequency in Jam-A null sperm bear a strikingfirms the immunocytochemistry data. Immunogold labeling (arrowheads) of WT
n the surface of the head and on the principal piece (3). The control in 4, with no
he midpiece (MP) of the flagellum ofWT (1, 2) and Jam-A−/− (4, 5) sperm show
two pairs of males studied, there was a significant increase in electron dense
s. Null sperm (6) also showed defects in the principal piece (PP) in a higher
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Fig. 6. JAM-A is conserved in human sperm. Western blot analysis shows the
∼32 kDa JAM-A band from sperm protein extracts of 2 males in Lanes 1 and 2.
Lane 3 is blank and Lane 4, a positive control, shows recombinant human JAM-A
from Chinese hamster cells (CHO) transfected with human JAM-A cDNA
containing a hemagglutinin (HA) tag. Lane 5, a negative control, shows the
absence of JAM-A from mock-transfected CHO cells while Lane 6 is a positive
control showing endogenous JAM-A from human umbilical vein endothelial
cells (HUVEC) which are known to express high levels of the protein. The
loading control in the lower panel shows heat shock cognate protein 70 (HSC 70)
present for all samples, including the mock-transfected negative control.
254 M. Shao et al. / Developmental Biology 313 (2008) 246–255resemblance to those seen in hyperactivated motility defects of
sterile mice with the Plasma membrane Ca2+-ATPase 4
(Pmca4) gene disrupted (Schuh et al., 2004; Okunade et al.,
2004). The condensed mitochondria reflect Ca2+ overload
which occurs when efflux is inhibited in the absence of PMCA4
(the protein encoded by Pmca4), which is present on the prin-
cipal piece (Schuh et al., 2004; Okunade et al., 2004). We
propose that JAM-A and PMCA4 which co-localize on the
principal piece may interact in regulating Ca2+ efflux or may be
on the same signal transduction pathway, and will test this
hypothesis in future experiments.
In the principal piece, AKAP4 (A kinase Anchoring Protein
4) functions as a scaffolding protein for a variety of signal
transducing molecules. It anchors PKA (protein kinase A) to the
fibrous sheath and directs signal transduction pathways that
control motility (Miki et al., 2002). The importance of tyrosine
phosphorylation of flagellar proteins for sperm motility and its
correlation with hyperactivation (Si and Okuno, 1999) suggest
that JAM-A, which has a tyrosine phosphorylation site within
the PDZ domain-binding sequence at the cytoplasmic tail and
which binds to scaffolding proteins (Ebnet et al., 2004), may be
involved in the signal transduction pathway for hyperactivated
motility. Due to the presence of JAM-A on the sperm head, it is
also possible that it might be involved in the protein phos-
phorylation associated with capacitation (Galantino-Homer et
al., 1997). These possibilities will also be investigated in future
studies.
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